CP
Christopher Peetz (CHIEF EXECUTIVE OFFICER) filed 9 Form 4 reports in the trailing twelve months (0 purchases, 9 sales), most often in Mirum Pharmaceuticals, Inc. (MIRM). The largest single filing was $3.8M of MIRM (40,985 sh × $91.98, as filed), executed Mar 16. Data as of Nov 7 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
9
0 buys · 9 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$18.0M
shares × price, as filed
Last traded
Nov 4
Filed Nov 4
Median ADV $83.1M across their filed names
Open performance→Volume by month
Buys $0
Sells $26.9M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
9 filings
Sector per market data · by filing · past 12 months
Most traded names
MIRMRecent filings
MIRMSALE
Mirum Pharmaceuticals, Inc.
View filing →
$1.8M20,000 sh × $90.00
Exec Nov 4
Filed Nov 4 · 8:46 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $3.0M
30,000 sh across 2 lots
Exec Sep 1
Filed Sep 3 · 6:52 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $2.0M
20,000 sh across 3 lots
Exec Aug 10
Filed Aug 11 · 5:41 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $2.4M
20,000 sh across 4 lots
Exec Jul 6
Filed Jul 8 · 5:12 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $2.8M
29,117 sh across 5 lots
Exec Jun 1
Filed Jun 2 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $3.8M
40,985 sh × $91.98
Exec Mar 16
Filed Mar 17 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $941K
9,108 sh × $103.30
Exec Feb 2
Filed Feb 3 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $657K
6,831 sh × $96.19
Exec Jan 26
Filed Jan 27 · 5:30 PM ET More filings →